Distinguished in Thoracic Aortic Aneurysm

Hiroki G. Tanaka

Osaka, JP 
Distinguished in Thoracic Aortic Aneurysm
Osaka, JP 
OverviewLocationsClinical Research

Overview

Hiroki Tanaka practices in Osaka, Japan. Mr. Tanaka is rated as a Distinguished expert by MediFind in the treatment of Thoracic Aortic Aneurysm. His top areas of expertise are Abdominal Aortic Aneurysm (AAA), Thoracic Aortic Aneurysm, Lung Metastases, Endoscopy, and Orchiectomy.

His clinical research consists of co-authoring 570 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 29 articles in the study of Thoracic Aortic Aneurysm.

Gender
Male

Locations

Osaka, Japan
Other Locations
Kyoto, Japan
Suita, 5650871, Japan
Kusatsu, 5258577, Japan
Nagoya, 4648603, Japan
Shinjuku, 1628655, Japan
Asahikawa, 0788510, Japan
Sendai, 9808578, Japan
Suzuka, Japan
Miyazaki, Japan
Yokohama, 2210022, Japan
Ibaraki, Japan
Health And Nutrition, Japan
Kitakyushu, Japan
Sennan, 5900494, Japan
Yoyogi, Japan
Kanazawa, 9208640, Japan
Sapporo, 0600815, Japan
Machida, 1948610, Japan
Mitaka, Japan
Yayoi, 1130032, Japan
Tokyo, 1628655, Japan
Matsumoto, Japan
Chuo, 2600856, Japan
Ikoma, Japan
Tamagawa, 1948610, Japan
Chiba, 2608675, Japan
Katsura, Japan
Kawahara, 6068507, Japan
Hamamatsu, 4313192, Japan
Nara-shi, Japan
Kumatori, Japan
Chuo, 1040045, Japan
Shibuya, Japan
Fujimoto, Japan
Sayama, Japan
Nishi, 8190395, Japan
Akashi, Japan
Gifu-shi, 5011194, Japan
Tokushima, 7708503, Japan
Kameoka, Japan
Okazaki, Japan
Shizuoka, Japan
Fukuoka, Japan
Kawasaki, 2118510, Japan
Minato, Japan
Toon, Japan
Kanagawa, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

570 Total Publications

Myeloid-mesenchymal crosstalk drives ARG1-dependent profibrotic metabolism via ornithine in lung fibrosis.
Myeloid-mesenchymal crosstalk drives ARG1-dependent profibrotic metabolism via ornithine in lung fibrosis.
Journal: The Journal of clinical investigation
Published: August 28, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Tanaka's expertise for a condition
ConditionClose
View All 10 Advanced Conditions
View All 118 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile